Therapeutic Advances and Future Prospects in Immune-Mediated Inflammatory Myopathies

av Dalakas, Marinos C.
Publicerad 2008

Future perspectives in target-specific immunotherapies of myasthenia gravis

av Dalakas, Marinos C.
I publikationen Ther Adv Neurol Disord (2015)

Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future

av Dalakas, Marinos C.
I publikationen Neurotherapeutics (2015)

Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost

av Dalakas, Marinos C.
I publikationen Ther Adv Neurol Disord (2017)

Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies

av Dalakas, Marinos C.
I publikationen Ther Adv Neurol Disord (2018)

Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system

av Dalakas, Marinos C.
I publikationen Ther Adv Neurol Disord (2018)

Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease: More to come with myositis in the offing

av Dalakas, Marinos C.
I publikationen Neurol Neuroimmunol Neuroinflamm (2020)

Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications

av Dalakas, Marinos C.
I publikationen Acta Myol (2020)

Autoimmune Neurogenic Dysphagia

av Stathopoulos, Panos, Dalakas, Marinos C.
I publikationen Dysphagia (2021)

Expression of the Costimulatory Molecule BB-1, the Ligands CTLA-4 and CD28, and their mRNA in Inflammatory Myopathies

av Murata, Ken-ya, Dalakas, Marinos C.
Publicerad 1999

Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease

av Goldfarb, Lev G., Dalakas, Marinos C.
Publicerad 2009

Practical considerations on the use of rituximab in autoimmune neurological disorders

av Kosmidis, Mixalis L., Dalakas, Marinos C.
Publicerad 2010

Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease

av Goldfarb, Lev G., Dalakas, Marinos C.
Publicerad 2010

The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors

av Dalakas, Marinos C., Spaeth, Peter J.
I publikationen Ther Adv Neurol Disord (2021)

Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials

av Alexopoulos, Harry, Biba, Angie, Dalakas, Marinos C.
I publikationen Neurotherapeutics (2015)

Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder

av Rakocevic, Goran, Alexopoulos, Harry, Dalakas, Marinos C.
I publikationen BMC Neurol (2019)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications

av Dalakas, Marinos C., Bitzogli, Kleopatra, Alexopoulos, Harry
I publikationen Front Immunol (2021)

GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions

av Tsiortou, Popianna, Alexopoulos, Harry, Dalakas, Marinos C.
I publikationen Ther Adv Neurol Disord (2021)

Efficacy of Intravenous Immunoglobulin in Neurological Diseases

av Lünemann, Jan D., Quast, Isaak, Dalakas, Marinos C.
I publikationen Neurotherapeutics (2015)

Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy

av Rakocevic, Goran, Martinez-Outschoorn, Ubaldo, Dalakas, Marinos C.
I publikationen Neurol Neuroimmunol Neuroinflamm (2018)